Clinical Trial Update: Efficacy of the SeQuent®Please in the Treatment of De-novo Stenoses Versus Taxus™Liberté™ [Phase 3]

View source ↗

Summary

Phase 3 trial comparing SeQuentPlease to Taxus Liberté for coronary de-novo stenosis was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Coronary De-novo Stenosis

Drugs mentioned

• SeQuentPlease (SeQuentPlease)
• TAXUS Liberté (paclitaxel-eluting stent)

Snippet

Sponsor: University Hospital, Saarland | Conditions: Coronary De-novo Stenoses | Phase 3 | Status: TERMINATED